116 related articles for article (PubMed ID: 8000375)
1. Anti-osteopenic effect of nasal salmon calcitonin in type 1 osteoporotic rats: comparison with subcutaneous dosing.
Ichikawa M; Nakamuta H; Hoshino T; Ogawa Y; Koida M
Biol Pharm Bull; 1994 Jul; 17(7):911-3. PubMed ID: 8000375
[TBL] [Abstract][Full Text] [Related]
2. Histomorphometrical evaluation of anti-osteopenic effect of nasal salmon calcitonin in a type 1 osteoporotic model of rats.
Nitta T; Hoshino T; Koida M; Nakamuta H
Biol Pharm Bull; 1996 Feb; 19(2):214-6. PubMed ID: 8850308
[TBL] [Abstract][Full Text] [Related]
3. Bone anabolic effects of PTH(1-34) and salmon calcitonin in ovariectomy- and ovariectomy-steroid-induced osteopenic rats: a histomorphometric and biomechanical study.
Fukushima T; Nitta T; Furuichi H; Izumo N; Fukuyama T; Nakamuta H; Koida M
Jpn J Pharmacol; 2000 Mar; 82(3):240-6. PubMed ID: 10887955
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
5. Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the rat.
Mochizuki K; Inoue T
J Bone Miner Metab; 2000; 18(4):194-207. PubMed ID: 10874598
[TBL] [Abstract][Full Text] [Related]
6. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
DeLuca PP; Dani BA
AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
Nitta T; Fukushima T; Nakamuta H; Koida M
Jpn J Pharmacol; 1999 Mar; 79(3):379-86. PubMed ID: 10230867
[TBL] [Abstract][Full Text] [Related]
8. A comparison of estrogen and two different doses of calcitonin in ovariectomized rats.
Kavuncu V; Sahin S; Baydas G; Ilhan N; Ozercan I; Yasar A; Pekkutucu I; Ilhan N; Ozercan R
Yonsei Med J; 2003 Jun; 44(3):508-16. PubMed ID: 12833590
[TBL] [Abstract][Full Text] [Related]
9. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
Mosekilde L; Danielsen CC; Gasser J
Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats.
Wei J; Wang J; Gong Y; Zeng R
Mol Med Rep; 2015 Aug; 12(2):1717-26. PubMed ID: 25891179
[TBL] [Abstract][Full Text] [Related]
11. An acute and focal osteopenia model using ovariectomized rats: a rapid detection of the protective effect of salmon calcitonin.
Nakamuta H; Sasaki M; Ichikawa M; Koida M
Biol Pharm Bull; 1993 Mar; 16(3):325-7. PubMed ID: 8364484
[TBL] [Abstract][Full Text] [Related]
12. Femoral neck trabecular microstructure in ovariectomized ewes treated with calcitonin: MRI microscopic evaluation.
Jiang Y; Zhao J; Geusens P; Liao EY; Adriaensens P; Gelan J; Azria M; Boonen S; Caulin F; Lynch JA; Ouyang X; Genant HK
J Bone Miner Res; 2005 Jan; 20(1):125-30. PubMed ID: 15619678
[TBL] [Abstract][Full Text] [Related]
13. Plasma level monitoring of nasal salmon calcitonin in the rat by a heterogeneous two-site enzyme immunoassay.
Nakamuta H; Kohno T; Ichikawa M; Hoshino T; Watabe K; Koida M
J Clin Lab Anal; 1997; 11(3):129-31. PubMed ID: 9138100
[TBL] [Abstract][Full Text] [Related]
14. The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.
Davey RA; Morris HA
J Bone Miner Metab; 2005; 23(5):359-65. PubMed ID: 16133685
[TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
17. Salmon Calcitonin Attenuates Degenerative Changes in Cartilage and Subchondral Bone in Lumbar Facet Joint in an Experimental Rat Model.
Gou Y; Tian F; Kong Q; Chen T; Li H; Lv Q; Zhang L
Med Sci Monit; 2018 May; 24():2849-2857. PubMed ID: 29748528
[TBL] [Abstract][Full Text] [Related]
18. Effect of nasal salmon calcitonin on calcium and bone metabolism.
Thamsborg G
Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women.
Fioretti P; Gambacciani M; Taponeco F; Melis GB; Capelli N; Spinetti A
Maturitas; 1992 Dec; 15(3):225-32. PubMed ID: 1465036
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
